HL7 Implementation Guide for CDA® Release 2: Reporting to Public Health Cancer Registries from Ambulatory Healthcare Providers, Release 1 - US Realm

DESCRIPTION

Population-based cancer surveillance is critical in North America for cancer control activities aimed at reducing the morbidity and mortality of cancer, the second leading cause of death in the United States (U.S.) and the leading cause of death in Canada. Population-based public health central cancer registries across the U.S. and most of Canada are mandated to collect complete and timely cancer diagnostic, treatment, and outcome data from hospitals, physician offices, treatment centers, clinics, laboratories, and other sources. Recent shifts in cancer treatment away from hospital settings and towards ambulatory healthcare settings are increasing the importance of ambulatory (non-hospital) healthcare providers’ data for cancer surveillance. As ambulatory healthcare providers adopt modern electronic health record (EHR) systems, the opportunity to automate cancer registry reporting from ambulatory healthcare provider settings is also increasing and becoming more feasible. This document provides clear and concise specifications for electronic reporting from ambulatory healthcare provider EHR systems to public health central cancer registries using Health Level Seven (HL7) Clinical Document Architecture (CDA) based standards. This document is designed to guide EHR vendors and public health central cancer registries in the implementation of standardized electronic reporting. It includes both business rules and standardized specifications.

ALTERNATIVE NAMES

HL7 Implementation Guide for CDA® Release 2: Reporting to Public Health Cancer Registries from Ambulatory Healthcare Providers, Release 1 - US Realm may also go by the following names or acronyms:

TARGETS

•  Regulatory Agency
• Standards Development Organizations (SDOs)
• EHR, PHR Vendors
• Health Care IT Vendors
• Local and State Departments of Health
• Ambulatory healthcare providers

BENEFITS

• Increases the completeness, timeliness and accuracy of cancer surveillance data
• Provides a more secure means of reporting private information
• Enables ambulatory providers to meet public health jurisdictional and Meaningful Use reporting requirements through use of a single standardized specification
• Facilitates the implementation of an automated electronic process for the identification and reporting of cancer cases, treatment, and outcomes using ambulatory healthcare provider EHR systems to create a cancer event report and submit it to public health central cancer registries
• Reduces the burden on EHR and cancer registry systems through reuse of existing implementations based on CDA R2 and Consolidated CDA Release 2
• In the long term, reduces the resources required by ambulatory healthcare providers and public health central cancer registries to meet the objectives of cancer surveillance

IMPLEMENTATIONS/CASE STUDIES

• Kentucky Cancer Registry
• Tennessee Cancer Registry
• Centers for Disease Control and Prevention (CDC)

DEVELOPMENT BACKGROUND

This document represents a collaborative effort of the Centers for Disease Control and Prevention (CDC) National Program of Cancer Registries (NPCR), National Cancer Institute (NCI) Surveillance Epidemiology and End Results (SEER), public health central cancer registries, EHR vendors, and North American Association of Central Cancer Registries (NAACCR) to provide guidance to meet the Centers for Medicaid & Medicare Services (CMS) meaningful use objective for cancer reporting to a public health central cancer registry.

 

The CDC-NPCR and public health central cancer registry community developed the first Implementation Guide (IG) for electronic physician reporting to cancer registries was developed using CDA R2 within the Integrating the Healthcare Enterprise (IHE) Quality, Research and Public Health (QRPH) domain and the Physician Reporting to a Public Health Repository – Cancer Registry (PRPH-Ca) Profile was successfully tested at multiple IHE Connectathons. The HL7 specification portion of the IHE profile was used as the basis for the development of the CDC’s Implementation Guide for Ambulatory Healthcare Provider Reporting to Central Cancer Registries, Release 1.0, August 2012. The CDC 2012 IG is identified by the Office of the National Coordinator for Health Information Technology (ONC) Final Rule as the standard to be used for the Meaningful Use Stage 2 Menu Objective.

RELATED DOCUMENTS

HL7 Implementation Guide for CDA® Release 2: Reporting to Public Health Cancer Registries from Ambulatory Healthcare Providers, Release 1 - US Realm

(Download) (4.88 MB)

STU DOCUMENTS

	HL7 CDA® R2 IG: Reporting to Public Health Cancer Registries from Ambulatory Healthcare Providers, R1, DSTU Release 1.1 - US Realm	(Submit Feedback on STU)	(Download) (5.44 MB)
	HL7 Implementation Guide for CDA® Release 2: Reporting to Public Health Cancer Registries from Ambulatory Healthcare Providers, Release 1 - US Realm	Expiration Dec 2016	(Download) (4.88 MB)

TOPIC

• Public Health

BALLOT TYPE

• DSTU

STATUS DATE

2014-12-17

RESPONSIBLE WORK GROUPS

STAKEHOLDERS

• EHR, PHR Vendors
• Health Care IT Vendors
• Local and State Departments of Health
• Regulatory Agency
• Standards Development Organizations (SDOs)

FAMILY

• CDA

CURRENT STATE

• Stable

REALM

• US Realm